You are here: Industry Insights > BEACON

News List

Cyclerion Therapeutics and Beacon Biosignals Announce Expanded Strategic Partnership firstwordpharma
July 09, 2021
Cyclerion Therapeutics, Inc. (Nasdaq: CYCN) and Beacon Biosignals today announced an extended and expanded strategic partnership between the two companies.
Mycenax becomes Taiwan, China's first CDMO company to complete the CHO-S and CHOZN GS Cell Line Development with the Beacon(R) Optofluidic System prnasia
May 18, 2021
Mycenax becomes one of the first CDMO companies in Asia to adapt the Beacon Optofluidic system to cell line development services.
Eurofins Scientific Acquires Beacon Discovery contractpharma
February 20, 2021
Eurofins Scientific, a leader in bioanalytical testing, has acquired Beacon Discovery, a preeminent drug discovery and contract research organization (CRO) focused on G-Protein Coupled Receptor (GPCR) research.
Kodiak Sciences Treats First Patients in Three Phase 3 Studies of KSI-301 americanpharmaceuticalreview
October 10, 2020
Kodiak Sciences announced the first patients have been treated in the randomized, double-masked GLEAM, GLIMMER and BEACON studies, three pivotal Phase 3 studies of KSI-301, Kodiak's anti-VEGF antibody biopolymer conjugate ...